Early imaging biomarkers of lung cancer, COPD and coronary artery disease in the general population: rationale and design of the ImaLife (Imaging in Lifelines) Study

Lung cancer, chronic obstructive pulmonary disease (COPD), and coronary artery disease (CAD) are expected to cause most deaths by 2050. State-of-the-art computed tomography (CT) allows early detection of lung cancer and simultaneous evaluation of imaging biomarkers for the early stages of COPD, base...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Eur J Epidemiol
Autori principali: Xia, Congying, Rook, Mieneke, Pelgrim, Gert Jan, Sidorenkov, Grigory, Wisselink, Hendrik J., van Bolhuis, Jurjen N., van Ooijen, Peter M. A., Guo, Jiapan, Oudkerk, Matthijs, Groen, Harry, van den Berge, Maarten, van der Harst, Pim, Dijkstra, Hildebrand, Vonder, Marleen, Heuvelmans, Marjolein A., Dorrius, Monique D., De Deyn, Peter Paul, de Bock, Geertruida H., Dotinga, Aafje, Vliegenthart, Rozemarijn
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Netherlands 2019
Soggetti:
New Study
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7058676/
https://ncbi.nlm.nih.gov/pubmed/31016436
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10654-019-00519-0
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi